UnknownNot Applicable

Change of Circulating Tumor Cells During Laparoscopic or Transanal Endoscopic Surgery for Rectal Cancer.

China100 participantsStarted 2021-10-18

Plain-language summary

The primary purpose of this study is to compare the changes of circulating tumor cells (CTCs) at different time points in rectal cancer patients undergoing laparoscopic or transanal endoscopic radical resection. Our secondary purpose is to explore the effects of perioperative circulating tumor cells on tumor recurrence and metastasis.

Who can participate

Age range18 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion criteria

✓. Mid-low rectal cancer.
✓. Single lesion.
✓. No metastasis.
✓. Clinical Stage T2-3, N0-1.

Exclusion criteria

✕. History of malignant tumors.
✕. Acute bowel obstruction, bleeding or perforation.
✕. Received neoadjuvant treatment.
✕. Tumor over 6cm in diameter or in severe adhesion with surrounded tissues.
✕. Severe other contradictions of surgery.
✕. Pregnant women will be excluded.
✕. The patient suffered from massive hemorrhage.
✕. The operation mode needs to be changed according to the patient's condition.

What they're measuring

Change of circulating tumor cells during laparoscopic or transanal endoscopic surgery

Timeframe: 1 years

Trial details

NCT IDNCT05109130

SponsorSun Yat-sen University

Sponsor typeOTHER

Study typeOBSERVATIONAL

Primary completion2022-10-25

View on ClinicalTrials.gov More Rectal Neoplasms trials